April 27, 2020 -- Digital biology company Recursion has released an open-source RxRx19 dataset, the first human cellular morphological dataset of SARS-CoV-2, it said.
The company's goal in releasing the information is to help researchers in their efforts to research and manage COVID-19.
The dataset is comprised of information from experiments Recursion conducted in collaboration with Utah State University in Logan to explore the therapeutic potential of a library of 1,672 U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA)-approved or clinical-stage compounds for managing the effect of SARS-CoV-2 in human renal cortical epithelial (HRCE) cells, according to the firm. Recursion processed the data using a deep-learning neural network in an effort to identify phenotypic profiles.
The RxRx19 dataset will give researchers access to more than 300,000 fluorescent microscopy images, Recursion said. It can be downloaded here.
Copyright © 2020 scienceboard.net